Somulose 400 mg/ml + 25 mg/ml solution for injection
Somulose 400 mg/ml + 25 mg/ml solution for injection
Authorised
- Secobarbital sodium
- Cinchocaine hydrochloride
Product identification
Medicine name:
Somulose 400 mg/ml + 25 mg/ml solution for injection
Active substance:
- Secobarbital sodium
- Cinchocaine hydrochloride
Target species:
-
Cattle
-
Dog
-
Horse (non food-producing)
-
Cat
Route of administration:
-
Intravenous use
Product details
Active substance and strength:
-
Secobarbital sodium400.00/milligram(s)1.00millilitre(s)
-
Cinchocaine hydrochloride25.00/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QN05CB02
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Ireland
Available in:
-
Ireland
Package description:
- 50 ml in amber type I glass vial with red chlorobutyl rubber stopper and aluminium seal in cardboard box carton.
- 25 ml in amber type I glass vial with red chlorobutyl rubber stopper and aluminium seal in cardboard box carton.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Well-established use application (Article 13a of Directive No 2001/82/EC)
Marketing authorisation holder:
- Dechra Regulatory B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
- Eurovet Animal Health B.V.
Responsible authority:
- Health Products Regulatory Authority
Authorisation number:
- VPA22622/018/001
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
English (PDF)
Download Published on: 7/09/2025
